AII
AMED

AGF Investments Inc’s Amedisys AMED Stock Holding History

AGF Investments Inc’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23
Closed -$4K – 439
2021
Q4 		$4K Sell
23
-156,087
-100% -$25.1M ﹤0.01% 711
2021
Q3 		$23.3M Sell
156,110
-776
-0.5% -$161K 0.18% 138
2021
Q2 		$38.4M Buy
156,886
+16,218
+12% +$4.26M 0.29% 112
2021
Q1 		$37.2M Buy
140,668
+24,693
+21% +$6.96M 0.3% 110
2020
Q4 		$34M Buy
115,975
+24,352
+27% +$6.24M 0.29% 105
2020
Q3 		$21.7M Sell
91,623
-37
-0% -$8.41K 0.22% 130
2020
Q2 		$18.2M Buy
91,660
+51,660
+129% +$9.64M 0.19% 140
2020
Q1 		$7.34M Buy
40,000
+15,000
+60% +$2.67M 0.09% 175
2019
Q4 		$4.17M Buy
+25,000
New +$3.72M 0.05% 196

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AGF Investments Inc's AMED Position: Q1 2022 in Review

AGF Investments Inc sold out of Amedisys (AMED) in Q1 2022, closing a stake of 23 shares — an estimated $4K sold.

AGF Investments Inc first reported a position in AMED in Q4 2019 and held it in 9 quarters. The position peaked at $38.4M in Q2 2021. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • AGF Investments Inc reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 23 Amedisys shares in Q1 2022, an estimated $4K.
  • AGF Investments Inc first reported a position in Amedisys in Q4 2019 and held it in 9 quarters.
  • AGF Investments Inc's Amedisys position peaked at $38.4M in Q2 2021.
  • 328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.